https://www.selleckchem.com/peptide/avexitide.html
The lack of background disease incidence rates in sub-Saharan countries where the RTS,S/AS01 malaria vaccine is being implemented may hamper the assessment of vaccine safety and effectiveness. This study aimed to document baseline incidence rates of meningitis, malaria, mortality, and other health outcomes prior to vaccine introduction through the Malaria Vaccine Implementation Programme. An ongoing disease surveillance study is combining prospective cohort event monitoring and hospital-based disease surveillance in three study sites i
إعجاب
علق
شارك
